GPER immunostaining in tumor cells was significantly associated with sex (P = 0.043), negative HBsAg (P = 0.036), small tumor size (P = 0.002), and low serum AFP levels (P = 0.014, Table 1). Here, GPER1 is linked to neoplasm.